OMEGA HEALTHCARE INVESTORS INC financial data

Symbol
OHI on NYSE
Location
Hunt Valley, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 09 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 101% % -22%
Return On Equity 11% % 17%
Return On Assets 5.8% % 33%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 295,570,000 shares 4.9%
Common Stock, Shares, Outstanding 295,539,000 shares 5.9%
Entity Public Float $10,743,896,520 USD 23%
Common Stock, Value, Issued $29,553,000 USD 5.9%
Weighted Average Number of Shares Outstanding, Basic 291,648,000 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 304,952,000 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,190,099,000 USD 13%
General and Administrative Expense $104,137,000 USD 18%
Income Tax Expense (Benefit) $14,748,000 USD 36%
Net Income (Loss) Attributable to Parent $590,185,000 USD 45%
Earnings Per Share, Basic 1.96 USD/shares 25%
Earnings Per Share, Diluted 1.94 USD/shares 25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $27,024,000 USD -95%
Operating Lease, Right-of-Use Asset $27,283,000 USD -3.6%
Goodwill $644,626,000 USD 0.15%
Assets $10,049,059,000 USD 1.5%
Liabilities $4,608,560,000 USD -11%
Accumulated Other Comprehensive Income (Loss), Net of Tax $79,037,000 USD 248%
Retained Earnings (Accumulated Deficit) $4,677,092,000 USD 14%
Stockholders' Equity Attributable to Parent $5,181,299,000 USD 14%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5,440,499,000 USD 15%
Liabilities and Equity $10,049,059,000 USD 1.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $181,952,000 USD 20%
Net Cash Provided by (Used in) Financing Activities $347,698,000 USD -87%
Net Cash Provided by (Used in) Investing Activities $19,261,000 USD
Common Stock, Shares Authorized 700,000,000 shares 100%
Common Stock, Shares, Issued 295,539,000 shares 5.9%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $144,663,000 USD -77%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $54,563,000 USD -90%
Interest Paid, Excluding Capitalized Interest, Operating Activities $63,050,000 USD 7.9%
Deferred Tax Assets, Valuation Allowance $1,925,000 USD -4.9%
Operating Lease, Liability $29,512,000 USD -2.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $646,491,000 USD 62%
Deferred Tax Assets, Operating Loss Carryforwards $1,800,000 USD -12%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) $15,645,000 USD 30%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $8,693,033,000 USD 9.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $325,247,000 USD 6.8%
Share-based Payment Arrangement, Expense $44,200,000 USD 20%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%